A Case of Successful Medical Treatment of Ventricular Tachycardia in a Patient With Ischemic Heart Disease and Heart Failure

The pathogenetic mechanisms of arrhythmias, including  high-grade ventricular  arrhythmias (including non-sustained ventricular  tachycardia),  in patients with coronary  heart disease may be different. Therefore, the characteristics  of ventricular arrhythmias must be considered  based on the totality of data, taking  into account all the available features. The importance  of a personalized approach  to the management of a patient with coronary  heart disease who had extensive myocardial  infarction 18.5 years ago,  followed  by mammary  coronary  artery bypass  grafting, aneurysmectomy and the development of heart failure with a low ejection fraction, in whom ventricular arrhythmias occurred against the background of a stable course of coronary disease , but after emotional stress, is reflected in this work. An extended examination, as well as a detailed study of the nature of ventricular arrhythmias, made it possible  to determine  the main provoking factor and select an individualized pathogenetic treatment with a good  antiarrhythmic result that persists for several years of observation.  Conducting mental tests and psychological questioning can be recommended for patients with coronary  heart disease  and  chronic  heart failure as an additional  examination to assess  the contribution  of the psycho-emotional factor  to arrhythmogenesis after excluding the ischemic and sympathetic  nature of ventricular ectopia. It is incorrect to consider that all ventricular arrhythmias  in patients with coronary heart disease are ischemic in nature, and in some clinical situations this statement is even erroneous.

1. Ulus T, Kudaiberdieva G, Gorenek B. The onset mechanism of ventricular tachycardia Int J Cardiol. 2013;167(3):619-23. DOI:10.1016/j.ijcard.2012.09.034.

2. Gorenek B, Kudaiberdieva G, Birdane A, et al. Initiation of monomorphic ventricular tachycardia: electrophysiological, clinical features, and drug therapy in patients with implantable defibrillators. J Electrocardiol. 2003;36(3):213-8. DOI:10.1016/s0022-0736(03)00051-7.

3. Golukhova EZ, Gromova OI, Bulaeva NI, Bokeria LA. Sudden cardiac death in patients with coronary heart disease: from mechanisms to clinical practice. Kardiologiia. 2017;57(12):73-81 (In Russ.) DOI:10.18087/cardio.2017.12.10069.

4. Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-77. DOI:10.1093/eurheartj/ehz425.

5. 2020 Clinical Practice Guidelines of the Ministry of Health of the Russian Federation. Ventricular arrhythmias. Ventricular tachycardia and sudden cardiac death 2020 [cited 2022 Jan 26]. Available from: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_ZHNR.pdf.

6. Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ Res. 1971;29(5):437-45. DOI:10.1161/01.res.29.5.437.

7. Critchley HD, Taggart P, Sutton PM, et al. Mental stress and sudden cardiac death. Brain. 2005;128(1):75–130. DOI:10.1093/brain/awh324.

8. Tsurinova EA. Acute and chronic psychoemotional stress in the genesis of ventricular arrhythmias. Translational Medicine. 2014;(2):18-25 (In Russ.)

9. Chmelevsky MP, Zubarev SV, Budanova MA. Non-invasive electrophysiological mapping in the diagnosis of ventricular arrhythmias: from research to clinical practice. Translational medicine. 2015;(5):91-103 (In Russ.)

10. Steptoe A, Vögele D. Methodology of mental stress testing in cardiovascular research. Сirculation. 1991;83(2):14-24.

11. Chutko LS, Rozhkova FV, Sidorenko VA et al. Generalized anxiety disorder: psychosomatic aspects and treatment approaches. Journal of Neurology and Psychiatry 2012;112(1):40-4 (In Russ.)

12. Kovalenko VN, Nesukay EG, Dmitrichenko EV. Correction of autonomic dysfunction in patients with essential hypertension and neurocirculatory dystonia. Leakey. 2005;(1-2):118-24 (In Ukr.)

13. Gromov L, Dudko E. Typical and atypical tranquilizers. Vestnik Pharmacologii and Pharmacii. 2003;10:7-11 (In Ukr.)

14. Ryngach EA, Treshkur TV, Tatarinova AA, Shlyakhto EV. Algorithm for the management of patients with stable coronary heart disease and high-grade ventricular arrhythmias. Ter Arkhiv. 2017;89(1):94-102 (In Russ.) DOI:10.17116/terarkh201789194-102.